Albiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III program-Reference-Cited by-同舟云学术

Albiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III program

Published:2017-10-30 Issue:8 Volume:129 Page:849-857
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Davidson Jaime A.¹,Jones-Leone Angela²,Wilson Timothy H.³,Nino Antonio⁴,Forero-Schwanhaeuser Sergio²,Reinhardt Rickey R.⁴

Affiliation:

1. Touchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX, USA

2. Medical Affairs, GlaxoSmithKline, Collegeville, PA, USA

3. GlaxoSmithKline, Research Triangle Park, NC, USA

4. Research and Development, GlaxoSmithKline, Collegeville, PA, USA

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1387473

Reference28 articles.

1. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2017. Atlanta (GA): U.S. Department of Health and Human Services; 2017. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

2. Centers for Disease Control and Prevention. At a glance 2016. Diabetes: working to reverse the epidemic. Atlanta (GA): U.S. Department of Health and Human Services; 2016. Available from: https://www.cdc.gov/chronicdisease/resources/publications/aag/pdf/2016/diabetes-aag.pdf

3. Prevalence of Diabetes Among Hispanics/Latinos From Diverse Backgrounds: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

4. Increased Incidence of Type II Diabetes Mellitus in Mexican Americans

5. Type 2 diabetes is prevalent and poorly controlled among Hispanic elders of Caribbean origin

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 diabetics followed up by family physicians: Treatment sequences and changes over time in weight and glycated hemoglobin;Primary Care Diabetes;2022-10